These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
6616 related items for PubMed ID: 15562833
1. The IGF receptor as anticancer treatment target. Macaulay VM. Novartis Found Symp; 2004; 262():235-43; discussion 243-6, 265-8. PubMed ID: 15562833 [Abstract] [Full Text] [Related]
2. Development of molecular agents for IGF receptor targeting. Salisbury AJ, Macaulay VM. Horm Metab Res; 2003; 35(11-12):843-9. PubMed ID: 14710367 [Abstract] [Full Text] [Related]
11. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Zhang H, Pelzer AM, Kiang DT, Yee D. Cancer Res; 2007 Jan 01; 67(1):391-7. PubMed ID: 17210722 [Abstract] [Full Text] [Related]
12. The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours. Höpfner M, Baradari V, Huether A, Schöfl C, Scherübl H. Endocr Relat Cancer; 2006 Mar 01; 13(1):135-49. PubMed ID: 16601284 [Abstract] [Full Text] [Related]
13. Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling. Mitsiades CS, Mitsiades N. Expert Rev Anticancer Ther; 2005 Jun 01; 5(3):487-99. PubMed ID: 16001956 [Abstract] [Full Text] [Related]
14. Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway. Lee YJ, Imsumran A, Park MY, Kwon SY, Yoon HI, Lee JH, Yoo CG, Kim YW, Han SK, Shim YS, Piao W, Yamamoto H, Adachi Y, Carbone DP, Lee CT. Lung Cancer; 2007 Mar 01; 55(3):279-86. PubMed ID: 17134788 [Abstract] [Full Text] [Related]